-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Why Is Clearmind (CMND) Stock Up 40% Today?
The jump in Clearmind sent its market cap to $6 million. The study of psychedelic compounds to treat mental illness is growing.
Why Is iCoreConnect (ICCT) Stock Up 19% Today?
iCoreConnect stock is rallying on Wednesday as investors in ICCT shares celebrate the company's acquisition of Verifi Dental.
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now.
Why Is Canopy Growth (CGC) Stock Down 8% Today?
Although Canopy Growth issued a private placement deal to bolster its finances, investors have taken a dim view of CGC stock.
NexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidation
NEXI stock is rising higher ahead of a potential liquidation and dissolution of NexImmune. Here's what you need to know.
10 Things to Know as Gotham City Slams Grifols (GRFS) Stock in New Short Report
GRFS stock is plunging lower following accusations of undisclosed related party transactions and financial irregularities.
Why Is Sarepta Therapeutics (SRPT) Stock Up Today?
Sarepta Therapeutics stock is rising higher on Tuesday as SRPT investors react to positive comments from company CEO Douglas Ingram.
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today?
Cyclacel Pharmaceuticals stock is slipping on Tuesday after shares of CYCC rallied on Monday alongside it regaining Nasdaq compliance.
Why Is Grifols (GRFS) Stock Down 38% Today?
Grifols stock is falling hard as investors sell GRFS shares after the company was hit with a short report from Gotham City Research.
Why Is Elicio Therapeutics (ELTX) Stock Up 11% Today?
Elicio Therapeutics stock is up with heavy trading of ELTX shares are posting positive preliminary results from a Phase 1 clinical trial.
3 Stocks to Capitalize on the Telehealth Explosion
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.
Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?
With Johnson & Johnson buying out Ambrx Biopharma, the win-win deal boosted AMAM stock while better positioning J&J’s oncology unit.
Why Is Axonics (AXNX) Stock Up 20% Today?
Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific.
